Enocitabine
Jump to navigation
Jump to search
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | IV |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C31H55N3O6 |
Molar mass | 565.796 g·mol−1 |
3D model (JSmol) | |
| |
|
Enocitabine (INN, marketed under the brand name Sunrabin) is a nucleoside analog used as chemotherapy.
Sunrabin contains the emulsifier HCO-60, which can cause allergic reactions.[1]
References
- (in Japanese) Sunrabin[permanent dead link]
Categories:
- CS1 Japanese-language sources (ja)
- Articles with short description
- Short description matches Wikidata
- Drugs not assigned an ATC code
- Drugs with non-standard legal status
- Chemical pages without DrugBank identifier
- Articles containing unverified chemical infoboxes
- Articles with Japanese-language sources (ja)
- All articles with dead external links
- Articles with dead external links from August 2019
- Articles with permanently dead external links
- Antineoplastic drugs
- All stub articles
- Antineoplastic and immunomodulating drug stubs